4 News & Press Releases found
Radiopharm Theranostics News
-
Pivalate’s additional data released from positive Phase II imaging trial in brain metastases
Sydney, Australia - November 23, 2022 - Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that Imperial College London has ...
-
Radiopharm Theranostics signs agreement with ANSTO for the supply of key isotope lutetium-177
bydney, Australia - November n, lull — Kaaiopnarm I neranostics (A:>a:kauj, a aeveioper or a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce agreement with Australia`s ...
-
Successful completion of Retail Entitlement Offer
Radiopharm Theranostics Limited (ASX:RAD, RAD or the Company), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce the successful completion of the retail component ...
-
Extension of Retail Entitlement Offer
Radiopharm Theranostics Limited (ASX:RAD, "RAD" or the "Company"), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, refers to its fully underwritten non-renounceable entitlement issue ...